Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater ...

KRISHNAGIRI: A 15-year-old girl from Hosur who has been diagnosed with an autoimmune disease is in need of a critical ...

Please provide your email address to receive an email when new articles are posted on . Learning from 2 decades of off-label rituximab use in systemic lupus erythematosus may point the way toward ...

Although the study was conducted at a single center, patients achieved clinical improvement and cessation of steroid therapy.

Objective—The TrialNet Study Group evaluated rituximab, a B-cell–depleting monoclonal antibody, for its effect in new-onset patients with type 1A diabetes. Rituximab decreased the loss of C ...

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

Rituximab may be an effective therapeutic option in the management of severe necrotizing scleritis associated with AAV.

EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ — Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, ...

Research shows nearly 20% of patients with pemphigus experience relapse. An additional dose of rituximab in patients with a predictor for relapse reduced the relapse rate (2.6%). Patients with ...

However, recent advancements in antibody absorption columns and drugs such as Rituximab that target B cells, have improved ...

Calquence in combination with bendamustine and rituximab has been recommended for approval in the European Union, EU, for ...